Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia

Elemraid, M. A., Rushton, S. P., Shirley, M. D. F., Thomas, M. F., Spencer, D. A., Eastham, K. M., Hampton, F., Gorton, R., Pollard, K., Gennery, A. R. and Clark, J. E. (2013) Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia. Epidemiology and Infection, 141 8: 1697-1704. doi:10.1017/S0950268812002257

Author Elemraid, M. A.
Rushton, S. P.
Shirley, M. D. F.
Thomas, M. F.
Spencer, D. A.
Eastham, K. M.
Hampton, F.
Gorton, R.
Pollard, K.
Gennery, A. R.
Clark, J. E.
Title Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia
Journal name Epidemiology and Infection   Check publisher's open access policy
ISSN 0950-2688
Publication date 2013-01-01
Year available 2013
Sub-type Article (original research)
DOI 10.1017/S0950268812002257
Open Access Status Not yet assessed
Volume 141
Issue 8
Start page 1697
End page 1704
Total pages 8
Place of publication Cambridge, United Kingdom
Publisher Cambridge University Press
Language eng
Abstract In September 2006, the 7-valent pneumococcal conjugate vaccine (PCV7) was added to the UK immunization programme. We aimed to evaluate the impact of PCV7 on the incidence of all-cause community-acquired pneumonia (CAP) in children. A prospective survey was undertaken in 2008-2009 at 11 hospitals in North East England of children aged 0-16 years with radiologically confirmed pneumonia. Data were compared to those from a similar survey undertaken in the same hospitals in 2001-2002. A total of 542 children were enrolled, of which 74% were aged <5 years. PCV7 uptake was 90·7%. The incidence of pneumonia was 11·8/10 000 [95% confidence interval (CI) 10·9-12·9], and the hospitalization rate was 9·9/10 000 (95% CI 9·0-10·9). Compared to 2001, there was a 19% (95% CI 8-29) reduction in the rate of CAP in those aged <5 years, and in those <2 years a 33·1% (95% CI 20-45) reduction in the incidence of CAP and 38·1% (95% CI 24-50) reduction in hospitalization rates. However, for those unvaccinated aged ≥5 years, there was no difference in the incidence of CAP and hospitalization rate between both surveys. Since 2001, the overall reduction in incidence was 17·7% (95% CI 8-26) and for hospitalization 18·5% (95% CI 8-28). For the <5 years age group there was a lower incidence of CAP in PCV7-vaccinated children (25·2/10 000, 95% CI 22·6-28·2) than in those that were not vaccinated (37·4/10 000, 95% CI 29·2-47·1). In conclusion, PCV7 has reduced both incidence and rate of hospitalization of pneumonia in children, particularly in the <2 years age group.
Keyword Children
Pneumococcal conjugate vaccine
Q-Index Code C1
Q-Index Status Provisional Code
Grant ID 0887X1-4479
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Psychology Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 18 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 22 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 12 Dec 2015, 05:18:21 EST by System User on behalf of School of Psychology